Anticancer combination comprising docetaxel and an antisense oligonucleotide

Details for Australian Patent Application No. 2009316773 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Graff, Jeremy Richard

Agent FB Rice

Pub. Number AU-A-2009316773

PCT Pub. Number WO2010/059589

Priority 61/116,861 21.11.08 US

Filing date 17 November 2009

Wipo publication date 27 May 2010

International Classifications

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/059589 Priority application(s): WO2010/059589

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316776-Combination anesthesia and scavenger surgical mask

2009316769-Conductive film formation on glass